Confidential page 1/396

“Det er kriminelt af EMA at beholde denne medicin på markedet”

Hemmelige dokumenter frigivet af BioNTech til Det Europæiske Lægemiddelagentur (EMA) afslører tusindvis af dødsfald og titusindvis af alvorlige bivirkninger blandt mennesker, der fik Pfizer-BioNTechs mRNA COVID ‘vacciner,’ samtidig med at vaccinefabrikanterne “ikke registrerede nogle sikkerhedsadvarsler, og med at vaccinen viste 91 procents effektivitet.”

Dokumenterne blev gjort tilgængelige for den østrigske videnskabs- og politikblog TKP den 4 marts efter en Freedom of Information- forespørgsel fra en anonym læser, men intet europæisk medie har rapporteret om dem siden.

“Confidential” documents released by BioNTech to the European Medicines Agency reveal tens of thousands of serious adverse events and thousands of deaths among people who received the Pfizer-BioNTech mRNA COVID-19 vaccine during a time period when the vaccine makers insisted they saw no “safety signals.”

The documents, dated Aug. 18, 2022, and marked “confidential,” show that cumulatively, during the clinical trials and post-marketing period up to June 18, 2022, a total of 4,964,106 adverse events were recorded. The documents included an appendix with further details about the specifics about the identified adverse events.

“Pfizer knew about a sickening level of injury early on. The company observed 1.6 million adverse events covering nearly every organ of the body”

“These adverse event reports are ‘off the charts,’ with myocarditis reports at over 10,000 and pericarditis reports at over 9,000.

“Historically, we know that this would be an under-ascertainment of the actual numbers. It is criminal for the EMA to keep this vaccine on the market.”

There were 3,280 fatalities among vaccine recipients in the combined cumulative period including the clinical trials and post-marketing, up to July 18, 2022. According to Daniel Horowitz, the documents “show that Pfizer knew about a sickening level of injury early on,” yet continued to distribute its COVID-19 vaccine.

Pfizer-BioNTech: Ingen sikkerhedsproblemer trods tusinder af døde

Et lille uddrag af dødsfald og alvorlige bivirkninger

Stroke: 3,091 cases and 3,532 serious adverse events during PSUR #3, including 314 fatalities, and 19 cases during the clinical trial (one death).
The document stated, “Cerebral venous sinus thrombosis … and Cerebrovascular Accident/Stroke were evaluated as signals during the reporting period and were not determined to be risks causally associated with the vaccine … No additional safety signals … have emerged based on the review of these cases.”

Respiratory: 2,199 cases and 1,873 serious adverse events during PSUR #3, including 363 fatalities, and 33 cases during the clinical trial (four deaths). Serious adverse events included cardio-respiratory arrest, pneumonia, respiratory failure, acute respiratory failure, hypoxia and acute respiratory distress syndrome. Yet, “No safety signals have emerged based on the review of these cases.”

Bell’s palsy: 733 cases were reported during PSUR #3, in addition to 1,428 cases of facial paralysis. Six cases were fatal, with all victims over age 60. One additional case of Bell’s palsy, in a 75-year-old female from the U.S., was recorded in the clinical trial but was deemed “not related” to her vaccination. Again, “No new significant safety information was identified.”

Neurological: 5,111 cases and 4,973 serious adverse events during PSUR #3, including 67 fatalities, and 15 cases during the clinical trial. Once more, “No safety signals have emerged based on the review of these cases.”

Immune-mediated/autoimmune adverse events: 11,726 cases and 8,445 serious adverse events during PSUR #3, including 133 fatalities, and 19 cases during the clinical trial. Serious adverse events included thrombocytopenia, interstitial lung disease, cerebral hemorrhage, encephalitis, multiple organ dysfunction syndrome, renal failure, pneumonia and pulmonary embolism. Yet, “No new safety signals have emerged.”

Multisystem inflammatory syndrome: 207 cases and 210 serious adverse events during PSUR #3, including 56 deaths, with 35 involving the elderly. In addition, 38 cases were reported in children. Nevertheless, “No new safety signals have emerged based on a review of these cases [or] literature.” Pfizer-BioNTech stated a “commitment” for “closely monitoring multisystem inflammatory syndrome in children and in adults … and reporting of new cases.”

Thromboembolic adverse events: 6,102 cases and 6,724 serious adverse events during PSUR #3, including 265 fatalities, and 17 cases during the clinical trial (one death). Serious adverse events included pulmonary embolism, thrombosis and deep vein thrombosis. Again, “No safety signals have emerged based on the review of these cases.”

Elsewhere in the document, the case of a 14-year-old male who died of peripheral swelling after getting the COVID-19 vaccine was mentioned, with no additional details. In another example, a 67-year-old male “with a history of diabetes and idiopathic thrombocytopenic purpura” suffered chest and gastrointestinal discomfort less than 30 minutes after receiving his third dose of the vaccine. A diagnosis of anaphylaxis was made, while an electrocardiogram showed “signs of a myocardial infarction.” He later sustained cardiac arrest and died 12 days following his vaccination.

Moreover, 204 fatalities (and 24,077 cases) of vaccination failure, 81 deaths from “vaccination stress,” 24 deaths (and 1,402 cases) of suspected vaccination failure, two deaths from glomerulonephritis and nephrotic syndrome, two deaths (1,326 cases) from “medication error” and 166 deaths from “other” adverse events — mostly pyrexia — were recorded.  23.6.2023: ‘Criminal’: Confidential EU Documents Reveal Thousands of Deaths From Pfizer-BioNTech Shots.

Horowitz: Confidential Pfizer document shows the company observed 1.6 million adverse events covering nearly every organ system